Author:
Silva Daniel-Adriano,Yu Shawn,Ulge Umut Y.,Spangler Jamie B.,Jude Kevin M.,Labão-Almeida Carlos,Ali Lestat R.,Quijano-Rubio Alfredo,Ruterbusch Mikel,Leung Isabel,Biary Tamara,Crowley Stephanie J.,Marcos Enrique,Walkey Carl D.,Weitzner Brian D.,Pardo-Avila Fátima,Castellanos Javier,Carter Lauren,Stewart Lance,Riddell Stanley R.,Pepper Marion,Bernardes Gonçalo J. L.,Dougan Michael,Garcia K. Christopher,Baker David
Publisher
Springer Science and Business Media LLC
Reference91 articles.
1. Akdis, M. et al. Interleukins, from 1 to 37, and interferon-γ: receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 127, 701–721 (2011).
2. Smyth, M. J., Cretney, E., Kershaw, M. H. & Hayakawa, Y. Cytokines in cancer immunity and immunotherapy. Immunol. Rev. 202, 275–293 (2004).
3. Lotze, M. T. et al. In vivo administration of purified human interleukin 2. II. Half life, immunologic effects, and expansion of peripheral lymphoid cells in vivo with recombinant IL 2. J. Immunol. 135, 2865–2875 (1985).
4. Moraga, I. et al. Synthekines are surrogate cytokine and growth factor agonists that compel signaling through non-natural receptor dimers. eLife 6, e22882 (2017).
5. Vazquez-Lombardi, R. et al. Potent antitumour activity of interleukin-2–Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells. Nat. Commun. 8, 15373 (2017).
Cited by
400 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献